Elanco Animal Health (ELAN) Total Non-Current Liabilities (2017 - 2026)

Elanco Animal Health's (ELAN) quarterly Total Non-Current Liabilities came in at $6.3 billion in Q1 2026, up 2.52% year-on-year from $6.1 billion in Q1 2025, and little changed quarter-over-quarter from $6.2 billion in Q4 2025.

Elanco Animal Health (ELAN) Total Non-Current Liabilities (2017 - 2026) Analysis & Trends

Elanco Animal Health has disclosed Total Non-Current Liabilities across 10 years of filings, most recently posting $6.3 billion for Q1 2026.

  • Total Non-Current Liabilities for Q1 2026 came in at $6.3 billion, up 2.52% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.3 billion (up 2.52% YoY), and the FY2025 annual result was $6.2 billion, changed 0.16% from the prior year.
  • Total Non-Current Liabilities came in at $6.3 billion for Q1 2026 at Elanco Animal Health, roughly flat from $6.2 billion in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $8.4 billion in Q1 2022 to a low of -$183.0 million in Q2 2022.
  • The 5-year median for Total Non-Current Liabilities is $7.4 billion (2024), against an average of $6.7 billion.
  • Across the five-year window, Total Non-Current Liabilities tumbled 102.12% in 2022 and soared 4452.46% in 2023, its largest moves.
  • Elanco Animal Health's Total Non-Current Liabilities stood at $8.0 billion in 2022, then slipped by 3.07% to $7.7 billion in 2023, then fell by 19.57% to $6.2 billion in 2024, then advanced by 0.16% to $6.2 billion in 2025, then rose by 0.47% to $6.3 billion in 2026.
  • The last three Total Non-Current Liabilities figures came in at $6.3 billion (Q1 2026), $6.2 billion (Q4 2025), and $6.2 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 18.28 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 11.64 Bn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 599.10 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 44.12 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 1.24 Bn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 6.26 Bn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 2.44 Bn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 1.13 Bn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 1.81 Bn
10 Liquidia 5.63 Bn 5.40 Bn 121.79 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 6.26 Bn
Dec 31, 2025 6.23 Bn
Sep 30, 2025 6.20 Bn
Jun 30, 2025 6.33 Bn
Mar 31, 2025 6.10 Bn
Dec 31, 2024 6.22 Bn
Sep 30, 2024 6.17 Bn
Jun 30, 2024 7.36 Bn
Mar 31, 2024 7.49 Bn
Dec 31, 2023 7.73 Bn
Sep 30, 2023 7.78 Bn
Jun 30, 2023 7.97 Bn
Mar 31, 2023 8.04 Bn
Dec 31, 2022 7.97 Bn
Sep 30, 2022 7.98 Bn
Jun 30, 2022 -183.00 Mn
Mar 31, 2022 8.40 Bn
Dec 31, 2021 8.71 Bn
Sep 30, 2021 8.66 Bn
Jun 30, 2021 8.62 Bn